When the CD4 count seems too good to be true.
Investigators found these populations are younger and are living at or below poverty were at lower adherence to ART.
This training will empower pharmacists practicing in LTC facilities to develop antimicrobial stewardship programs, improve patient outcomes related to infectious diseases, and facilitate compliance with CMS requirements.
A retrospective study found hepatitis C reinfection rates high are in HIV-positive men who have sex with men from four western European countries.
Lefamulin, a recently approved pleuromutilin, adds to the current antibiotic armamentarium, although its place in therapy remains to be seen.
Thomas Lodise, PharmD, PhD, provides an overview of options for treating community-acquired bacterial pneumonia and highlights the challenges of the infection.
A shocking find on a CT scan leads to an unexpected diagnosis.
Researchers have found that an experimental vaccine designed to fight the Ebola virus has proven to be highly protective.
Evidence is accumulating that influenza vaccination protection wanes over the course of a single influenza season, with significant implications for public health.
The official cause of death is still under investigation by the New Mexico Office of the Medical Investigator, though the individual tested positive for the measles virus.
A collaborative, international effort aims to answer tough antimicrobial resistance questions.
The interconnectedness of many healthcare facilities such as nursing homes, hospitals, and long-term acute-care hospitals means a significant chance of multidrug-resistant organism transmission when patients shuttle between facilities.
Contagion® radio is here to bring joy with every new antibiotic alert!
Noting successful HIV/AIDS prevention efforts rely on early diagnosis, an analysis estimates that improved access to health insurance through the Affordable Care Act will increase the number of patients getting tested for HIV by nearly 500,000 over a 5-year period, though that impact would be amplified if all US states opted to expand Medicaid coverage.
President Donald Trump broke the news last night via Twitter.
The only way individuals can reduce their risk of getting shingles is to get vaccinated; luckily, a new vaccine has recently been approved by the FDA.
A patient with HIV and skin lesions should trigger a broad differential.
Treating Clostridioides difficile infection is complicated in patients coinfected with COVID-19. However, a new study suggests a significant benefit of fecal microbiota transplant (FMT) in these coinfected patients.
New public health perspectives on aspergillosis, sporotrichosis, histoplasmosis, and coccidioidomycosis.
There has been increasing interest in the association between neural tube defects, dolutegravir, and integrase inhibitors as a class since 4 cases were reported in 2018.
The vaccine is approved as a 3-dose series, which consists of a 0.5 mL intramuscular injection, administered at 2, 4, and 6 months of age.
Novel modes of delivery are imperative to improve HIV suppression and prevent transmission.
The FDA has granted QIDP and Fast Track Designations for the oral formulation of SCY-078 for the treatment of vulvovaginal candidiasis.
Alnylam Pharmaceuticals announces exclusive licensing agreement with Vir Biotechnology for the development and commercialization of RNA Interference therapeutics for infectious diseases.
To better support the use of critical antibiotics, the Centers for Medicare & Medicaid Services revised the rules governing reimbursement for qualifying antibiotic products. For these changes to succeed, hospital systems will need to make adjustments.
The FDA has finalized its guidance on how to synchronize development of antimicrobials and antimicrobial susceptibility test devices.
A shocking find on a CT scan leads to an unexpected diagnosis.